We are an innovation studio reimagining the path to parenthood

"In 2021, I was part of a team at my former company evaluating possible investment in Robyn. During this initial assessment, I was immediately struck by the Robyn team’s deep understanding of the US fertility space, the patient experience, and their unmet needs. My respect grew when I learned more about their tangible accomplishments in addressing these needs—and their strategic plans to not just provide support to individuals seeking to build healthy families but to also improve these outcomes. Company leadership enthusiastically endorsed a broader collaboration with Robyn, which ultimately led to a formal agreement signed in February 2022. Shortly thereafter, I approached Robyn leadership to ask if there might be interest in expanding the scope of their platform to provide patient support and education to those considering participation in clinical trials. Again, I was impressed by the culture of proactivity at Robyn and by their ability to think outside of the box. I strongly believe in Robyn’s commitment and continuing contribution to this field."

"I have had the privilege of working with the Robyn team over the past three years and have been consistently impressed by their professionalism, expertise, and dedication. During our time working together, Robyn demonstrated exceptional communication, seamless tech integration, consistent data and insights and overall just a wonderful working relationship. I am confident that they will bring the same level of commitment and excellence to any future endeavors."

"We’ve had the privilege of working with the Robyn team on a number of initiatives over the past year. We chose to work with the Robyn team because of their deep experience in the fertility space and their mission to make family-planning resources more accessible to those who need them. Through ongoing collaborative efforts with their team, we were able to identify creative ways to market to and engage with male consumers, who are typically less involved in the fertility conversation. With the Robyn team’s innovative thinking and guidance, we were able to create compelling messaging to consumers that resulted in very strong email open rates and click through rates. They have been amazing thought partners to us and we’re looking forward to working with them again to change the outdated view of fertility as a woman’s issue."

"In 2021, I was part of a team at my former company evaluating possible investment in Robyn. During this initial assessment, I was immediately struck by the Robyn team’s deep understanding of the US fertility space, the patient experience, and their unmet needs. My respect grew when I learned more about their tangible accomplishments in addressing these needs—and their strategic plans to not just provide support to individuals seeking to build healthy families but to also improve these outcomes. Company leadership enthusiastically endorsed a broader collaboration with Robyn, which ultimately led to a formal agreement signed in February 2022. Shortly thereafter, I approached Robyn leadership to ask if there might be interest in expanding the scope of their platform to provide patient support and education to those considering participation in clinical trials. Again, I was impressed by the culture of proactivity at Robyn and by their ability to think outside of the box. I strongly believe in Robyn’s commitment and continuing contribution to this field."